1. Home
  2. RVTY

as of 01-22-2026 3:58pm EST

$117.74
+$1.21
+1.04%
Stocks Industrials Biotechnology: Laboratory Analytical Instruments Nasdaq

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Founded: 1937 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 11.7B IPO Year: N/A
Target Price: $113.46 AVG Volume (30 days): 1.2M
Analyst Decision: Buy Number of Analysts: 14
Dividend Yield:
0.24%
Dividend Payout Frequency: Quarterly
EPS: 1.99 EPS Growth: -3.35
52 Week Low/High: $81.36 - $128.28 Next Earning Date: 02-02-2026
Revenue: $2,813,367,000 Revenue Growth: 3.37%
Revenue Growth (this year): 5.3% Revenue Growth (next year): 3.03%

AI-Powered RVTY Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 0.00%
0.00%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Revvity Inc. News

RVTY Breaking Stock News: Dive into RVTY Ticker-Specific Updates for Smart Investing

All RVTY News

Share on Social Networks: